This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Peptide Receptor Radionuclide Therapy (PRRT) Market

Market Insights on Peptide Receptor Radionuclide Therapy (PRRT) covering sales outlook, demand forecast & up-to-date key trends

Peptide Receptor Radionuclide Therapy (PRRT) Market by Indication, End User & Region - Forecast 2022-2032

Peptide Receptor Radionuclide Therapy (PRRT) Market Outlook

The market is likely to record a strong CAGR of 7.2% during the forecast period. The market is currently valued at US$ 552.08 Mn in 2022 and is likely to reach US$ 1,106.50 Mn by 2032.

Report Attribute

Details

Estimated Base Year Value (2022)

US$ 552.08 Mn

Anticipated Forecast Value (2032)

US$ 1,106.50 Mn

Projected Growth Rate (2022-2032)

7.2% CAGR

Sales of peptide receptor radionuclide therapy (PRRT) have risen due to the advancement and growing research in the medical industry leading to a surge in the availability of new cancer treatment options.

Increasing clinical trials and development activities to create therapeutic radiopharmaceuticals are also projected to contribute to the growth of the peptide receptor radionuclide therapy (PRRT) market share.

The report sheds light on the factors improving the sales of peptide receptor radionuclide therapy (PRRT), and, in turn, the opportunities for market players. However, the peptide receptor radionuclide therapy (PRRT) market also faces some challenges, which might limit the peptide receptor radionuclide therapy (PRRT) market share from reaching its potential.

Some of the key market trends promoting the demand for peptide receptor radionuclide therapy (PRRT) includes recommendation for the somatostatin receptor-positive gastroenteropancreatic NETs affected patients, establishment of reimbursement policies for Lutathera, increasing government and private organizations funding for cancer drugs and therapy development, increasing prevalence of neuroendocrine tumors as an increasing number of the patient pool and increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer therapy.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Dynamics to the Peptide Receptor Radionuclide Therapy (PRRT) Market Share

Increasing prevalence of neuroendocrine tumors are expected to impel the demand for peptide receptor radionuclide therapy (PRRT) as an increasing number of the patient pool.

Establishment of reimbursement policies for Lutathera favors the demand for peptide receptor radionuclide therapy (PRRT).

A temporary insurance/billing code was used for the peptide receptor radionuclide therapy (PRRT) till 2018. Moreover, increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer therapy expected to surge the growth in the demand for peptide receptor radionuclide therapy (PRRT).

Increasing government and private organizations funding for cancer drugs and therapy development is another major factor expected to propel the growth of the sales of peptide receptor radionuclide therapy (PRRT).

Moreover, growing manufacturer’s interest in the radiopharmaceutical and cancer market flourish the growth of the peptide receptor radionuclide therapy (PRRT) market.

Side effects such as the transient decrease in blood counts, nausea and others associated with PRRT expected to hamper the growth of the sales of peptide receptor radionuclide therapy (PRRT).

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Region holds the Highest Growth Potential in the Peptide Receptor Radionuclide Therapy (PRRT) Market

North America and Europe region are expected to grebe more than half of the market share for peptide receptor radionuclide therapy.

Increasing clinical trials for radiopharmaceuticals and growing demand for the targeted therapy for cancer are the major factors driving the growth of the peptide receptor radionuclide therapy market in the U.S. and European countries.

The Asia pacific peptide receptor radionuclide therapy market expected to grow with significant growth rate as growing demand for advance treatment option and comparatively high prevalence of cancer in India and China.

How is the Competitive Landscape in the Peptide Receptor Radionuclide Therapy (PRRT) Market

The key players of the peptide receptor radionuclide therapy (PRRT) market are focusing on enhancing and adopting strategies like enhancing the durability, sizes and its use as testing equipment to thrive business. This is driving the sales of peptide receptor radionuclide therapy (PRRT).  

Some of the key participating players indulged in the sales of peptide receptor radionuclide therapy (PRRT) are:

  • Advanced Accelerator Applications (AAA) (Novartis AG)

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

These market players are anticipated to drive the peptide receptor radionuclide therapy (PRRT) market by introducing new products and expanding geographically.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 7.2% from 2022 to 2032

Base year for estimation

2022

Historical data

2015 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

Indication, End User, Region

Regional scope

North America; Latin America; Western Europe; Eastern Europe; Asia Pacific; Japan; Middle East and Africa (MEA)

Country scope

U.S., Canada, Mexico, Brazil, Germany, Italy, France, U.K, Spain, Poland, Russia, India, China, ASEAN, Australia & New Zealand, Japan, GCC Countries, South Africa, Northern Africa

Key companies profiled

Advanced Accelerator Applications (AAA) (Novartis AG)

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

The peptide receptor radionuclide therapy (PRRT) market grows at a rate of 7.2% CAGR during the forecast period 2022 to 2032.

Key players holding a substantial peptide receptor radionuclide therapy (PRRT) market share include Advanced Accelerator Applications (AAA) (Novartis AG).

Demand for peptide receptor radionuclide therapy (PRRT) is likely to rise on the back of increased clinical trials and development activities to create therapeutic radiopharmaceuticals are also projected to contribute to the growth of the peptide receptor radionuclide therapy (PRRT) market share.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Cell Therapy Systems Market

Published : September 2017

Healthcare

Continuous Renal Replacement Therapy Market

Published : July 2017

Healthcare

Anti-Osteoporosis Therapy and Fracture Healing Market

Published : February 2021

Healthcare

Compression Therapy Market

Published : August 2020

Google translate

Peptide Receptor Radionuclide Therapy (PRRT) Market